Yuko Oka

730 total citations
18 papers, 410 citations indexed

About

Yuko Oka is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuko Oka has authored 18 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuko Oka's work include Ion channel regulation and function (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Renin-Angiotensin System Studies (4 papers). Yuko Oka is often cited by papers focused on Ion channel regulation and function (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Renin-Angiotensin System Studies (4 papers). Yuko Oka collaborates with scholars based in Japan and Poland. Yuko Oka's co-authors include Hideki Itoh, Minoru Horie, Keiko Tsuji, Mizuo Miyazaki, Seiko Ohno, Takeru Makiyama, Hideki Okunishi, Tatsuhiko Kawamoto, Masaharu Akao and Yukiko Nishio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Analytica Chimica Acta.

In The Last Decade

Yuko Oka

18 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuko Oka Japan	12	294	208	45	37	29	18	410
Hugh Clements‐Jewery United Kingdom	10	382 1.3×	276 1.3×	50 1.1×	39 1.1×	17 0.6×	19	562
P POOLEWILSON United Kingdom	8	279 0.9×	173 0.8×	68 1.5×	32 0.9×	9 0.3×	12	442
F. James Brennan Canada	11	246 0.8×	131 0.6×	42 0.9×	25 0.7×	9 0.3×	26	405
Bo‐Wei Wu China	12	219 0.7×	216 1.0×	59 1.3×	18 0.5×	10 0.3×	36	332
H. M. Piper Germany	7	133 0.5×	146 0.7×	21 0.5×	108 2.9×	8 0.3×	8	332
G Grupp United States	6	180 0.6×	247 1.2×	41 0.9×	24 0.6×	22 0.8×	9	328
Jan Christian Reil Germany	10	214 0.7×	92 0.4×	23 0.5×	38 1.0×	24 0.8×	13	342
Thomas Sowa Germany	6	328 1.1×	309 1.5×	77 1.7×	32 0.9×	27 0.9×	6	429
Julián Torres-Jácome Mexico	10	181 0.6×	135 0.6×	38 0.8×	34 0.9×	20 0.7×	15	305
Mohsen Nayebpour Iran	13	248 0.8×	97 0.5×	22 0.5×	33 0.9×	10 0.3×	43	418

Countries citing papers authored by Yuko Oka

Since Specialization

Citations

This map shows the geographic impact of Yuko Oka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Oka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Oka more than expected).

Fields of papers citing papers by Yuko Oka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Oka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Oka. The network helps show where Yuko Oka may publish in the future.

Co-authorship network of co-authors of Yuko Oka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Oka. A scholar is included among the top collaborators of Yuko Oka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Oka. Yuko Oka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kuzumaki, Naoko, Reiko Kagawa, Yuko Oka, et al.. (2019). Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations. Molecular Brain. 12(1). 5–5. 18 indexed citations

Kato, Tadashi, Naoyuki Miyashita, Yasuhiro Kawai, et al.. (2016). Changes in physical function after hospitalization in patients with nursing and healthcare-associated pneumonia. Journal of Infection and Chemotherapy. 22(10). 662–666. 18 indexed citations

Takizawa, Tomoko, et al.. (2012). A Study of Clinical Training and Evaluation for the Preparation of a Full-Veneer Crown. Annals of Japan Prosthodontic Society. 4(4). 434–443. 3 indexed citations

Kimura, Hiromi, Yuka Mizusawa, Hideki Itoh, et al.. (2011). Carvedilol, a Non‐Selective β‐with α1‐Blocker is Effective in Long QT Syndrome Type 2. SHILAP Revista de lepidopterología. 27(4). 324–331. 1 indexed citations

Oka, Yuko, Hideki Itoh, Wei‐Guang Ding, et al.. (2010). Atrioventricular Block-Induced Torsades de Pointes With Clinical and Molecular Backgrounds Similar to Congenital Long QT Syndrome. Circulation Journal. 74(12). 2562–2571. 12 indexed citations

Makiyama, Takeru, Masaharu Akao, Satoshi Shizuta, et al.. (2008). A Novel SCN5A Gain-of-Function Mutation M1875T Associated With Familial Atrial Fibrillation. Journal of the American College of Cardiology. 52(16). 1326–1334. 148 indexed citations

Sakaguchi, Tomoko, Hideki Itoh, Wei‐Guang Ding, et al.. (2008). Hydroxyzine, a First Generation H1-Receptor Antagonist, Inhibits Human Ether-a-go-go–Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG Mutation. Journal of Pharmacological Sciences. 108(4). 462–471. 24 indexed citations

Sakaguchi, Tomoko, Wataru Shimizu, Hideki Itoh, et al.. (2008). Age‐ and Genotype‐Specific Triggers for Life‐Threatening Arrhythmia in the Genotyped Long QT Syndrome. Journal of Cardiovascular Electrophysiology. 19(8). 794–799. 23 indexed citations

Nagaoka, Iori, Wataru Shimizu, Hideki Itoh, et al.. (2008). Mutation Site Dependent Variability of Cardiac Events in Japanese LQT2 Form of Congenital Long-QT Syndrome. Circulation Journal. 72(5). 694–699. 19 indexed citations

10.

Itoh, Hideki, Keiko Tsuji, Tomoko Sakaguchi, et al.. (2007). A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. International Journal of Cardiology. 121(3). 239–248. 7 indexed citations

11.

Nagaoka, Iori, Takashi Ashihara, Hideki Ito, et al.. (2007). . Japanese Journal of Electrocardiology. 27(3). 246–252. 1 indexed citations

12.

Matsuo, Shinro, Yuichi Sato, Ichiro Nakae, Yuko Oka, & Minoru Horie. (2006). Cardioverter defibrillator implantation in a patient with double chambered right ventricle. International journal of cardiac imaging. 23(4). 459–462. 1 indexed citations

13.

Jin, Denan, Keifu Song, Yuko Oka, et al.. (1997). Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo. The Japanese Journal of Pharmacology. 75(3). 259–266. 12 indexed citations

14.

Okunishi, Hideki, Yuko Oka, Naotaka Shiota, et al.. (1993). Marked Species-Difference in the Vascular Angiotensin II-Forming Pathways: Humans versus Rodents. The Japanese Journal of Pharmacology. 61(4). 371–373. 17 indexed citations

15.

Okunishi, Hideki, Keifu Song, Yuko Oka, et al.. (1993). In Vitro Pharmacology of a Novel Non-Peptide Angiotensin II-Receptor Antagonist, E4177. The Japanese Journal of Pharmacology. 62(4). 351–355. 14 indexed citations

16.

Aoki, Toyoaki, et al.. (1993). Continuous-flow method for the determination of total inorganic carbonate in water. Analytica Chimica Acta. 284(1). 167–171. 24 indexed citations

17.

Okunishi, Hideki, et al.. (1991). PATHOGENETIC ROLE OF VASCULAR ANGIOTENSIN‐CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT. Clinical and Experimental Pharmacology and Physiology. 18(9). 649–659. 63 indexed citations

18.

Oka, Yuko, et al.. (1978). Circulatory response to tracheal intubation in patients with coronary artery disease and valvular disease.. PubMed. 54(9). 842–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact